Ustekinumab and Omalizumab
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-04734432014L0024active
Estimated value
—
goods
Awarded value
—
Suppliers
8
5 SME
Lots
2
2 awarded
Published
11 Sept 2024
Description
Supply of Ustekinumab and Omalizumab to NHS Scotland
Scope
- Reference
- NP47924de
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality Criterion: API Source | 5 | quality | — |
| — | 95 | price | — |
| API Source | 5 | quality | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 2 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 2 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Ustekinumab | — | cancelled |
| 2 | Omalizumab | — | cancelled |